drugset / Trial / NCT00546754
BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333)
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the blood pressure efficacy between losartan and valsartan at equivalent dosage during a 3 months treatment.
Timeline
- Start
- 2007-05-01
- Primary completion
- 2009-04-01
- Completion
- 2009-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Losartan | Other / unclassified | 50 mg | — |
| Subject | Losartan | Other / unclassified | 100 mg | — |
| Comparator | Valsartan | Small molecule | 80 mg | — |
| Comparator | Valsartan | Small molecule | 160 mg | — |
| Comparator | Hydrochlorothiazide | Unknown | 12.5 mg | — |
| Comparator | Hydrochlorothiazide | Unknown | 25 mg | — |